via University of Turku
A research group at the University of Turku has led the development of a new method to evaluate vaccine safety. The new method may significantly reduce the use of animal testing in the vaccine industry.
Vaccines are safe and potent pharmaceutical products that prevent infectious diseases caused by viruses and bacteria, and reduce the spread of pathogens among the population. A vaccine prevents an infectious disease because the body develops an ability to recognise and destroy the pathogen. Vaccines are generally designed from a weakened pathogen, or parts of it. The vaccine industry uses effective methods to ensure vaccine safety, and constantly develops new methods as well.
The pertussis vaccine, which also belongs to the Finnish national vaccination programme, contains the surface structures of the pertussis bacteria and inactivated forms of the pertussis toxin produced by the bacteria. The pertussis toxin attaches to the surface of the cell, penetrates it, and destroys the vital control system of the cell.
The research group at the University of Turku has led the development of the new method that can be used to ensure the safety of the pertussis toxin in the pertussis vaccine. The new iGIST method (Interference in G?i-mediated Signal Transduction) detects how the pertussis toxin destroys the vital control system of the cell.
– Compared to the current methods in the vaccine industry, iGIST is more effective and enables the detection of up to 100 times lower levels of pertussis toxin. iGIST is entirely based on using laboratory grown, human-based cells. Therefore, it may significantly reduce the use of animal testing in the vaccine industry, says Dr Arto Pulliainen from the University of Turku who was the principal investigator of the research group that was in charge of developing the method.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Vaccine safety
- Moderna: FDA Extends RSV Vaccine Review, But No Issues Flagged
Moderna said the FDA hasn't informed the Cambridge, Mass., vaccine maker of any issues related to vaccine safety, efficacy or quality that would prevent the approval of mRNA-1345 for RSV, a contagious virus that is the leading cause of respiratory illness ...
- ‘Disclosed all rare side effects’: SII clarifies amid vaccine safety row
In India, the Serum Institute of India (SII) said it stopped the manufacturing of additional doses of Covishield since December 2021.
- Mumbai: Activists flag COVID vaccine safety concerns
Declarations like the vaccine’s ‘benefits outweighed risks’ is drama ... Several opposition leaders too have cited that PM Modi’s picture has disappeared since safety concerns have been flagged. Yet, several reports did state that the Election ...
- Global Vaccine Safety Assessment
The key opportunities to improve the resource limitations and methods in vaccine safety research are the availability of population-based electronic individual level immunization data and ...
Go deeper with Google Headlines on:
Vaccine safety
[google_news title=”” keyword=”vaccine safety” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Vaccine safety evaluation
- Jacob Rees-Mogg claims UK government 'downplayed' risks of AstraZeneca COVID vaccine
Jacob Rees-Mogg has claimed the government “downplayed” risks of the AstraZeneca COVID vaccine during the pandemic after it was announced the jab was being withdrawn from the worldwide market.
- Evaluation of a single-dose HPV vaccine strategy for promoting vaccine, health, and gender equity
Although several countries have adopted a single-dose human papillomavirus (HPV) vaccination strategy, many other countries continue to include multiple doses in their vaccination programmes. There ...
- Covid Vaccine – Is It India's Voldemort?
A significant source of distrust arises from the perception that India has not conducted sufficient in-depth research into vaccines and their side-effects. “Vaccines” have become akin to the ...
- New influenza vaccine strategies aim to enhance protection with T-cell responses
A recent review highlights the need for innovative influenza vaccines that combine T-cell and antibody responses to enhance protection across multiple strains and seasons.
- Covaxin Makers Claim No Side-Effects Of Their Vaccine Amidst Covishield Controversy
In light of AstraZeneca’s recent admission regarding potential side effects of its Covid vaccine, Covaxin’s manufacturer, Bharat Biotech, emphasizes its unwavering focus on safety. As Covidshield and ...
Go deeper with Google Headlines on:
Vaccine safety evaluation
[google_news title=”” keyword=”vaccine safety evaluation” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]